PRKN and Parkinson disease: DAQ modifications on tyrosine hydroxylase, the rate-limiting enzyme in DA synthesis, or parkin, whose coding sequence PARK2 is mutated in familiar PD, have been described in vitro and in vivo along with important inhibiting effects on protein functions [5], [6].